Filing Flows › Cardio Diagnostics Holdings (CDIO) › Q2 2025
Cardio Diagnostics Holdings (CDIO) Q2 2025 earnings results (second quarter 2025)
10-Q filed Aug 14, 2025
Cardio Diagnostics Holdings (CDIO) reported revenue of $7K for the second quarter 2025 (Q2 2025), -5% from a year earlier and +695% from the quarter before.
Cardio Diagnostics Holdings, Q2 2025: revenue $7K (-5% year over year), net loss $1.7M, operating cash flow −$1.6M. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $7K | +695% | -5% |
| Operating profit | −$1.7M | — | — |
| Net earnings | −$1.7M | — | — |
| Operating cash flow | −$1.6M | — | — |
What changed
Revenue was $7K in Q2 2025, down 5% year over year and up 695% from the previous quarter.
Operating costs exceeded revenue by $1.7M, an operating margin of -22457.5%. Total costs grew 31% against a revenue fall of 5%. The quarter ended with a net loss of $1.7M, wider than the previous quarter's $1.6M loss.
Operating cash flow was −$1.6M. Non-cash charges added back $8K of depreciation and amortization and $31K of share-based compensation. Capital expenditures of $19K exceeded it, leaving free cash flow of −$1.6M.
Questions
What was Cardio Diagnostics Holdings' revenue in the second quarter 2025?
Cardio Diagnostics Holdings (CDIO) reported revenue of $7K for the second quarter 2025 (Q2 2025), -5% from a year earlier and +695% from the quarter before.